RE: RE: BNC UNDERVALUED Plovie...It could even be closer to 60...but that still leaves 40 mil/40 cents a share after debt pay out for Animal Health alone.
That would leave the outright ownership of the VMC/Econiche and Urocidin as a net cost of roughly 12 mil/12 cents a share, with the valuation de jour.
You won't find too many corporations who have a $12,000,000 noose around their neck for owning a successful P3 cancer platform and a fully staffed vaccine plant, but you are lucky cause you own one here.